Three-Year Outcomes of the RESILIENT Trial: Are They Enough to Support a Primary Stenting Policy?

Abstract

Get full access to this article

View all access options for this article.

References

Laird

Katzen

Scheinert

Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.

J Endovasc Ther. 2012;19:1–9

Laird

Katzen

Scheinert

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.

Circ Cardiovasc Interv. 2010;3:267–276